CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study

• Jiahua Niu,
• Huiying Qiu,
• Fang Xiang,
• Lin Zhu,
• Jun Yang,
• Chongmei Huang,
• Kun Zhou,
• Yin Tong,
• Yu Cai,
• Baoxia Dong,
• Yuan Lu,
• Xuedong Sun,
• Liping Wan,
• Xueying Ding,
• Haopeng Wang,
• Xianmin Song

Affiliations

Jiahua Niu

Department of Hematology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine

Huiying Qiu

Department of Hematology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine

Fang Xiang

Hrain Biotechnology

Lin Zhu

Hrain Biotechnology

Jun Yang

Department of Hematology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine

Chongmei Huang

Department of Hematology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine

Kun Zhou

Department of Hematology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine

Yin Tong

Department of Hematology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine

Yu Cai

Department of Hematology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine

Baoxia Dong

Department of Hematology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine

Yuan Lu

Hrain Biotechnology

Xuedong Sun

Hrain Biotechnology

Liping Wan

Department of Hematology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine

Xueying Ding

Engineering Technology Research Center of Cell Therapy and Clinical Translation, Shanghai Science and Technology Committee (STCSM)

Haopeng Wang

School of Life Science and Technology, Shanghai Tech University

Xianmin Song

Department of Hematology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine